Back
Day Range
$299.69
$308.91
52-Week Range
$205.87
$495.55
Volume
1,494,718
50D / 200D Avg
$337.90
/
$392.53
Prev Close
$306.66
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 130.2 | 0.3 |
| P/B | 51.8 | 2.9 |
| ROE % | 73.3 | 3.7 |
| Net Margin % | 8.5 | 3.8 |
| Rev Growth 5Y % | 44.8 | 10.0 |
| D/E | 1.6 | 0.2 |
Analyst Price Target
Hold
$460.50
+49.5%
Low: $351.00
High: $549.00
Forward P/E
45.1
Forward EPS
$6.80
EPS Growth (est.)
+0.0%
Est. Revenue
5.6 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$19.29
$16.99 – $23.76
|
11 B | 14 |
| FY2029 |
$16.25
$14.31 – $20.01
|
10 B | 14 |
| FY2028 |
$13.74
$9.81 – $20.45
|
8.8 B | 16 |
Key Takeaways
Revenue grew 44.82% annually over 5 years — strong growth
ROE of 73.28% indicates high profitability
Generating 465.38M in free cash flow
P/E of 130.21 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 20.37%
Cash machine — converts 148.33% of earnings into free cash flow
Growth
Revenue Growth (5Y)
44.82%
Revenue (1Y)65.19%
Earnings (1Y)N/A
FCF Growth (3Y)233.09%
Quality
Return on Equity
73.28%
ROIC18.19%
Net Margin8.45%
Op. Margin13.51%
Safety
Debt / Equity
1.62
Current Ratio2.76
Interest Coverage1.99
Valuation
P/E Ratio
130.21
P/B Ratio51.77
EV/EBITDA80.70
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 65.19% | Revenue Growth (3Y) | 42.53% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 44.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.71B | Net Income (TTM) | 313.75M |
| ROE | 73.28% | ROA | 6.32% |
| Gross Margin | 81.77% | Operating Margin | 13.51% |
| Net Margin | 8.45% | Free Cash Flow (TTM) | 465.38M |
| ROIC | 18.19% | FCF Growth (3Y) | 233.09% |
| Safety | |||
| Debt / Equity | 1.62 | Current Ratio | 2.76 |
| Interest Coverage | 1.99 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 130.21 | P/B Ratio | 51.77 |
| P/S Ratio | 11.00 | PEG Ratio | -0.79 |
| EV/EBITDA | 80.70 | Dividend Yield | 0.00% |
| Market Cap | 40.85B | Enterprise Value | 40.48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.71B | 2.25B | 1.83B | 1.04B | 844.29M |
| Net Income | 313.75M | -278.16M | -440.24M | -1.13B | -852.82M |
| EPS (Diluted) | 2.33 | -2.18 | -3.52 | -9.30 | -7.20 |
| Gross Profit | 3.04B | 1.92B | 1.52B | 868.60M | 704.14M |
| Operating Income | 501.58M | -176.89M | -282.18M | -785.07M | -708.65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.97B | 4.24B | 3.83B | 3.55B | 3.64B |
| Total Liabilities | 4.18B | 4.17B | 4.05B | 3.70B | 3.06B |
| Shareholders' Equity | 789.18M | 67.09M | -220.64M | -158.22M | 588.20M |
| Total Debt | 1.28B | 2.74B | 1.31B | 1.32B | 997.59M |
| Cash & Equivalents | 1.66B | 966.43M | 812.69M | 866.39M | 819.98M |
| Current Assets | 4.05B | 3.30B | 2.98B | 2.69B | 2.81B |
| Current Liabilities | 1.47B | 1.19B | 967.79M | 767.92M | 695.71M |